GILD logo Gilead Sciences +
Gilead Sciences
+

Gilead Sciences (GILD) Business News

Track Gilead Sciences in real time with a live news feed covering Gilead Sciences stock news, official press releases, company announcements, and an archive of historical Gilead Sciences news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
8:52 PM | Sunday | Oct 11, 2026 Fool - Investing News

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

News Thumbnail
2:59 AM | Sunday | Oct 11, 2026 Defense World

Head to Head Contrast: Gilead Sciences (NASDAQ:GILD) vs. GRAIL (NASDAQ:GRAL)

News Thumbnail
2:59 AM | Sunday | Oct 11, 2026 Defense World

Head to Head Contrast: Gilead Sciences (NASDAQ:GILD) vs. GRAIL (NASDAQ:GRAL)

News Thumbnail
12:19 PM | Saturday | Oct 10, 2026 Fool - Investing News

Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma

News Thumbnail
7:01 PM | Friday | Oct 9, 2026 Zacks Investment Research

Gilead Sciences (GILD) Laps the Stock Market: Here's Why

News Thumbnail
9:02 AM | Sunday | Oct 4, 2026 Defense World

Gilead (NASDAQ: GILD) CEO sells 15,000 shares under a preset plan

News Thumbnail
6:50 PM | Friday | Oct 2, 2026 Zacks Investment Research

Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know

News Thumbnail
10:00 AM | Thursday | Oct 1, 2026 Zacks Investment Research

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

News Thumbnail
7:00 PM | Wednesday | Sep 30, 2026 Zacks Investment Research

Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors

News Thumbnail
4:31 AM | Saturday | Sep 26, 2026 Defense World

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts

News Thumbnail
7:15 AM | Friday | Sep 25, 2026 Reuters

Genetic discovery yields clues toward reversal of Alzheimer's brain damage

News Thumbnail
7:06 AM | Friday | Sep 25, 2026 ETF Trends

NTHM's Index Rebalance Puts Thematic Rotation to Work

News Thumbnail

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

Fool - Investing News

8:52 PM | Sunday | Oct 11, 2026

news photo
Loading...

Pharmaceutical stocks have been one of the best places to invest over the past year. Choosing between these two funds is really a question about how you want to own what comes next.

Read full article redirect
8:52 PM | Sunday | Oct 11, 2026

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

Fool - Investing News

Pharmaceutical stocks have been one of the best places to invest over the past year. Choosing between these two funds is really a question about how you want to own what comes next.

Read full article arrow
News Thumbnail
2:59 AM | Sunday | Oct 11, 2026

Head to Head Contrast: Gilead Sciences (NASDAQ:GILD) vs. GRAIL (NASDAQ:GRAL)

Defense World

Gilead Sciences (NASDAQ: GILD - Get Free Report) and GRAIL (NASDAQ: GRAL - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Valuation and Earnings This table compares Gilead Sciences and

Read full article arrow
News Thumbnail
2:59 AM | Sunday | Oct 11, 2026

Head to Head Contrast: Gilead Sciences (NASDAQ:GILD) vs. GRAIL (NASDAQ:GRAL)

Defense World

Gilead Sciences (NASDAQ: GILD - Get Free Report) and GRAIL (NASDAQ: GRAL - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Valuation and Earnings This table compares Gilead Sciences and

Read full article arrow
News Thumbnail
12:19 PM | Saturday | Oct 10, 2026

Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma

Fool - Investing News

BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their five-year returns diverged significantly.

Read full article arrow
News Thumbnail
7:01 PM | Friday | Oct 9, 2026

Gilead Sciences (GILD) Laps the Stock Market: Here's Why

Zacks Investment Research

Gilead Sciences (GILD) closed the most recent trading day at $151.17, moving +2.77% from the previous trading session.

Read full article arrow
News Thumbnail
9:02 AM | Sunday | Oct 4, 2026

Gilead (NASDAQ: GILD) CEO sells 15,000 shares under a preset plan

Defense World

What happened Gilead Sciences, Inc. (NASDAQ: GILD) said Chairman and CEO and director Daniel Patrick O'Day sold 15,000 shares on 2026-10-01. The stock went at prices from $147.72 to $148.63 a share, for about $2.
22 million total. The filing leaves O'Day with 566,683 shares after the trade. The filing lists the stock as common stock

Read full article arrow
News Thumbnail
6:50 PM | Friday | Oct 2, 2026

Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know

Zacks Investment Research

Gilead Sciences (GILD) closed the most recent trading day at $144.74, moving 1.87% from the previous trading session.

Read full article arrow
News Thumbnail
10:00 AM | Thursday | Oct 1, 2026

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
7:00 PM | Wednesday | Sep 30, 2026

Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors

Zacks Investment Research

In the latest trading session, Gilead Sciences (GILD) closed at $149.45, marking a -1.21% move from the previous day.

Read full article arrow
News Thumbnail
4:31 AM | Saturday | Sep 26, 2026

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts

Defense World

Gilead Sciences, Inc. (NASDAQ: GILD - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twenty-nine research firms that are covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating, twenty-three have issued a buy rating and one has assigned a strong buy rating to

Read full article arrow
News Thumbnail
7:15 AM | Friday | Sep 25, 2026

Genetic discovery yields clues toward reversal of Alzheimer's brain damage

Reuters

Today we highlight a discovery with potentially important implications for future Alzheimer's research and treatments. We also report on an experimental Gilead therapy showing great promise ​against a difficult-to-treat form of blood cancer, and an interesting new method for studying cells linked to age-related disorders.

Read full article arrow
News Thumbnail
7:06 AM | Friday | Sep 25, 2026

NTHM's Index Rebalance Puts Thematic Rotation to Work

ETF Trends

The latest rebalance of VettaFi's Thematic Rotation Quality Momentum Screened Index (TQRMS), tracked by the NBI Thematic Rotation ETF (NTHM:TSX), reshapes the portfolio around a new set of themes. GLP-1 weight loss drug manufacturers and midstream energy join the index, while battery technology & storage and software-as-a-service (SaaS) exit.

Read full article arrow
News Thumbnail